David Giarracco, Angel Investor

David Giarracco is a CEO, Board Member, and Angel Investor. He is a medical device executive with over twenty-five years of leadership experience spanning quality, engineering, and operations including product line, business integrations, and new product launches and six-sigma implementations for both operations and business process, and US and global marketing in surgical and monitoring environments. His leadership was crafted in big corporate America as well as within the start-up ecosystem. His experiences span business development (target identification, business case development, diligence), product development (concept through commercialization), into tactical commercial execution bringing innovative solutions to new sites. David currently serves as the CEO of Noninvasix, the first to non-invasively monitor the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time. He is also the Founder of Caudate Consulting and Advisor at NasaClip. As an angel investor, David has a strong focus on the medical industry.